Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of MicroRNA30a in Philadelphia Positive Leukemic Patients

NCT05112653 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05112653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05112653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
December 1, 2024
Enrollment
70 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

possibility of using microrna30a as a prognostic marker in philadelphia positive leukemic patients by measure level of microrna30a in blood sample